How are the many somatic cells (fibroblasts, kidney, muscle, liver, brain, etc.) of animals and man protected against intracellular infection-by antibodies or lymphocytes? In the event of lymphocyte participation, is immunity conferred directly to somatic cells, or indirectly via macrophages, which together with antibodies are sometimes held accountable for immunologically "shielding" the other body cells?
The passive protection conferred by antibodies, spleen cells, or lymph node cells was first demonstrated with intact infected animals (3, 7, 12, 32, 42) . Special circumstances were designed, either in vitro or in vivo, in order to analyze the roles of lymphocytes, macrophages, and mediators in the immunity against bacteria (10, 29, 34, 36) , viruses (35) , fungi (23) , and protozoa (9, 22, 25, 41) . Only in a few instances, when viruses did not grow well in macrophages, were other cells studied. For example, herpesvirus growing in rabbit kidney cells and adenovirus growing in mouse embryo fibroblasts were inhibited by lymphocytes from immune donors (19, 31) . Although these observations suggested that immune lymphocytes, through antibody or mediator, could protect somatic cells, we have found no categorical studies, other than on interferon, on how nonlymphoid cells, constituting most of the cells of the body, are immunologically pro-tected against infection. Exploration of this question was the aim of the present study. Because toxoplasmosis is an obligate intracellular infection where immune lymphocytes, but neither antibody nor interferon, significantly protect infected animals, Toxoplasma infection may also provide a suitable model to study cellular immunity in somatic cells. Infection with Besnoitia, a related protozoan exhibiting a specific immunity, was used to validate results and to test for the specificity of the immunity studied, controlling for the protective effect exerted by nonspecifically activated macrophages (13, 37, 47) . As will be shown, lymphocytes can directly confer immunity not only to macrophages, but also to fibroblasts and kidney cells. Furthermore, infection-specific mediators, with a molecular weight of 4,000 to 5,000, can be derived from immune lymphocytes in the presence of antigen, also conferring immunity to macrophages and somatic cells. MATERIALS Infections. The RH strain of Toxoplasma gondii and a cystless strain of Besnoitia jellisoni (strain A) noting that cells in culture were killed too rapidly by these strains, a different strain of Toxoplasma (T-45) and a cyst-producing line of Besnoitia were selected for the cell culture experiments.
The T-45 line of Toxoplasma (origin: Kansas City cat) gives rise to an asymptomatic acute, and later chronic, infection in mice and hamsters with few organisms. To obtain large numbers of Toxoplasma tachyzoites for inoculating cells in culture, chronically infected hamster brains were ground in 0.85% saline solution and inoculated intraperitoneally (i.p.) into mice treated with 2.5 mg of cortisone acetate subcutaneously (s.c.). Peritoneal exudate containing 105 tachyzoites per ml was harvested after 5 to 7 days. Cortisone treatment was necessary only to produce the first-passage acute infection in mice; subinoculation from mouse to mouse with 103 Toxoplasma organisms resulted in fatal infections.
To obtain tachyzoites of B. jellisoni, cysts taken from the surface of liver, spleen, and omentum of 3-month-infected mice were inoculated i.p. into cortisone-treated mice. After 6 to 7 days, more than 105 tachyzoites per ml could be harvested.
Immunization. Hamsters were inoculated s.c. with about 103 tachyzoites, either of the RH strain of T. gondii or a cystless strain of B. jellisoni. Sodium sulfadiazine (90 mg/100 ml) was given in the drinking water for 2 weeks, and the animals were homologously challenged s.c. 4 weeks after infection. If no death or illness was present within 2 weeks of challenge, the survivors were considered immune (22, 30) .
Hamster embryo cell cultures. Cells from 10-day-old embryos, obtained according to procedures described by Hayflick (20) , were grown in medium 199 (M-199), 10% heat-inactivated (60'C, 60 min) fetal calf serum (HIFCS), plus 100 U of penicillin and 100 tg of streptomycin per ml. Milk dilution bottles were used to obtain large numbers of cells. For the experiments, the cells were transferred to alcohol-cleaned, autoclaved cover slips (22 by 22 mm). These later were incubated at 370C in 5% CO2 in air.
Hamster kidney cell cultures. Kidneys of adult hamsters (80 to 135 g body weight) were used according to the methods of Gallagher (18) , with 0.25% trypsin in phosphate-buffered saline (PBS) and 0.02% ethylenediaminetetraacetic acid (EDTA). Then an equal volume of M-199 and 10% HIFCS was added to inactivate the trypsin, cells were spun down at 100 x g for 8 min, and the supernatant was poured off. The cells in the pellet were adjusted to 106/ml and inoculated into 8-ounce (about 240-ml) milk dilution bottles. Treatment with 0.1% trypsin in PBS with 0.02% EDTA was used to transfer either embryo or kidney cells from bottles to cover slips. All cultures were incubated at 37°C in an atmosphere of 5% CO2 in air.
Fibroblast cultures from brain and skin. Brain and skin fibroblasts were cultured by similar procedures, except that the total trypsinization period was 10 min for brain cells and 60 min for skin cells. Released brain cells were collected at 5 and 10 min; skin cells were collected every 10 min. Peritoneal exudate cell cultures. Normal and immune hamsters were "stimulated" with 6 ml of sterile 0.5% sodium caseinate in saline solution. To stimulate immunized hamsters, freeze-thaw-disrupted INFECT. IMMUN. homologous organisms (105 per hamster) were incorporated in the sodium caseinate solution. Five days later, cells were harvested by washing the peritoneal cavity with 10 to 12 ml of M-199. These cells were centrifuged at 100 X g for 8 min, and the supernatant was discarded; the sediment was diluted, and the number of cells was counted in a hemocytometer.
Lymphocytes. To separate lymphocytes, the macrophages of the washed peritoneal exudate components were removed by two 1-h periods in polyethylene petri dishes incubated at 37°C in 5% CO2 (22, 30) . The nonadherent cells were washed three times, centrifuged at 100 x g for 8 min, and adjusted to 106 cells/ml. The lymphocytes, usually showing 90 to 96% dye exclusion when stained with 0.1% toluidine blue, were added to target cells in a 1:1 ratio.
Preparation of mediator of immunity. Immune lymphocytes (105 to 106) were incubated (37°C, 5% CO2 in air) in the presence of 107 freeze-thaw-disrupted, homologous organisms for 24 h. After incubation, this material was centrifuged at 2,000 x g for 15 min. The supernatants were checked for the absence of lymphocytes and tested for antibody titer by means of the Sabin-Feldman dye test (14) . Those that were free of antibody and that transferred immunity to macrophages were designated as active supernatants, or mediator, and stored at -20°C.
Normal sera and antisera. Normal and Besnoitia or Toxoplasma antisera were inactivated at 56°C for 30 min and tested for contamination and antibody titer. Sera were frozen until used in the experiments. Normally serum concentrations of 10% were used.
Preparation of tachyzoite inoculum. Peritoneal exudate of mice infected for 2 to 3 days with Toxoplasma or Besnoitia was aspirated with M-199. Cells and organisms were washed by centrifugation to remove traces of antibody. Medium was added to resuspend the sediment, and the resultant suspension was passed eight times through a 27-gauge needle to disrupt cells, releasing intracellular tachyzoites. After another washing, the tachyzoites were resuspended in medium, counted in a hemocytometer, and added to the cultures as one organism per 10 6 ml of M-199 + 10% HIFCS + penicillin and streptomycin; 3 to 5 ml of medium plus peritoneal exudate was aspirated, and 2 ml was used to test infectivity in two mice (1.8 ml was injected i.p. into one mouse and 0.2 ml into another).
(ii) Subcutaneous infection site, lung, and brain. Tissues from the infection site, the whole lung, and brain were removed, ground separately with alundum, resuspended in 0.85% saline solution, and inoculated i.p. into two mice. The number of Toxoplasma inoculated was determined from the mean day of death by comparison with a titration curve relating inocula and survival time (similar to Fig. 3 (21) and analysis of variance (48) were performed.
Molecular-weight determination of the mediator. Gel filtration chromatography was carried out with columns (2 by 45 cm) of G-100 or G-50 fine Sephadex in PBS at pH 7.2; 2-ml fractions and a flow rate of 18 ml/h were used in all the experiments. Selected fractions were dialyzed in a 1:10 dilution of PBS, lyophilized, suspended in 10 to 20% of the original volume in M-199 sterilized by membrane filtration (Millipore Corp., Bedford, Mass.), and assayed for immune activity on kidney cells infected with Toxoplasma. To determine the approximate molecular weight of the mediator, the column was calibrated with insulin (molecular weight 5,700; Wellcome Laboratories), trypsin (molecular weight 24,000; Nutritional Biochemical Corp.), and cytochrome (molecular weight 12,000; Sigma Chemical Co.).
Temperature sensitivity of mediator. Portions of Toxoplasma-immune lymphocyte supernatants were stored at -70, -20, 4, and 220C for 2 weeks. Others were incubated at 370C for 48 
RESULTS
Fate of Toxoplasma in normal and immune hamsters. Hamsters were injected with 104 Toxoplasma in order to compare the dynamics of change in immune and in normal animals. One hour after infection, the number of Toxoplasma recovered from the i.p. and s.c. injection sites and the lungs of the immune hamsters was about 1 log lower than in the controls; no difference was noted in the brain (Fig. 1) . Because immune hamsters are chronically infected, an unchallenged group of immune hamsters was used as controls, providing base-line levels of infection in lung and brain. In both the peritoneal cavity and the s.c. injection site of the challenged immune hamsters, the 103 organisms recovered initially declined to undetectable levels 96 h after reinfection, whereas they reached about 107 in normal hamsters receiving a primary infection. No Toxoplasma was detected at these sites in the unchallenged immune controls. In the lungs and brain, the decline in number of challenge organisms followed a slower trend in the chronically infected animals, reaching the background level of 1 log Toxoplasma organisms for lung and 2.3 logs for brain after 120 to 144 h, whereas about 7 logs was recovered from the normal hamsters receiving primary infections. (Table 5) .
Molecular-weight determination of mediator. Toxoplasma supernatant was passed through a Sephadex G-50 column and compared with cell culture medium from nonimmune lymphocytes, antigen, and antibiotics. The void volume peaks at fraction 30 were identical in mediator and control, but the smaller peaks A and B were more pronounced in the active supernatants than in the controls. Besnoitia and Toxoplasma supernatants, when passed through Sephadex G-50, showed a similar pattern of peaks ( Fig. 5 and 6 ). The immune activity was identified in peak A of both the Toxoplasmaand Besnoitia-immune mediator (Table 6 , Fig.  7) . A calibration curve of the Sephadex G-50 column with insulin, cytochrome, and trypsin is shown in Fig. 8 . From this we estimate the molecular weight of peak A of our mediator to be between 4,000 and 5,000.
Host species specificity of mediator. The effect of the mediator derived from hamsters was examined in kidney cells of hamsters, mice, Table 3 .
C ND, Not done. and rhesus monkeys and in HeLa cells of human origin, infected with either organism. Both Toxoplasma and Besnoitia were inhibited by hamster-derived mediator only in hamster kidney cells (Table 7) . pared with 12.6 ± 1.4 days for the antibodyinjected hamsters and 11.3 ± 0.8 days for the control hamsters. The difference in mean survival times of mediator-injected and control hamsters was statistically significant (P < 0.01) for challenge inocula of 10 and 100 Besnoitia (Fig. 9) .
Determination of optimal conditions for use of mediator in fibroblasts. Because FIG. 8. Molecular-weight determination for the anti-Toxoplasma mediator of immunity. The Sephadex G-50 column was calibrated with trypsin, molecular weight 24,000; cytochrome, molecular weight 12,000; and insulin, molecular weight 5,700. Each fractional sample was 2 ml. 11, and 12). Supernatants alone (groups 7 and 12) were slightly but consistently more potent than supernatants with 24-h-old lymphoid cells (groups 6 and 11). Supernatants derived from the interaction of lymphocytes and antigen (groups 11 and 12) appeared to be as effective as supernatants from lymphocytes, macrophages, and antigen (groups 6 and 7). Antibody (groups 13 and 14) was effective against Besnoitia but not against Toxoplasma, although both antisera had a dye test titer of 1:16,000. DISCUSSION Macrophages, in which most forms of cellular immunity and resistance have been studied so far, constitute only a small fraction of the cell population of the body. It remained uncertain, therefore, how the majority of other body cells, somatic cells, were protected. That even brain cells beyond the blood-brain barrier are immunologically protected had been noted in mice challenged i.c. with Toxoplasma (11). Such mice survived 13 days after immunization without significant participation of lymphocytes or macrophages invading the brain, or probably of antibody, which does not even protect against extracerebral challenge (15, 17) .
To provide a clinical base line for this study, we challenged Toxoplasma-immune hamsters i.p., s.c., and i.c., comparing the parasite numbers in these sites and the lungs with those developing after primary infection (Fig. 1) . The approximate 1-log reduction in number of organisms isolated after 1 h from peritoneal cavity, s.c. site, and lungs of immune hamsters was probably due to antibody effects on extracellular organisms in these extracerebral sites. Intracerebral organisms were not affected. As illustrated by the dye test (40) , the antibody lyses extracellular organisms within 30 min in the presence of ac- study of Besnoitia immunity in the peritoneal cavity (22) , where the number of lymphocytes in the peritoneum also increased progressively between 48 and 120 h. This also appeared similar to the 5-day disappearance times observed for allogeneic tumor cells and for the second-set transplantation response (6) .
Having established the dynamics of the antiToxoplasma immune response in intact hamsters, we compared this response in vitro, in macrophages as previously studied (9, 22, 25, Fig. 2 and 3) . The corresponding immune components from Besnoitia-immune hamsters protected the same cultured cell types against Besnoitia (Table 1) .
The immune effects are expressed here as organisms per 100 cells, as organisms per 100 infected cells, and by the 24-to 1-h multiplication ratio based on each of these parameters (Table 1) . We have not used the calculated generation time, as used by others (25, 41) , because it may be easily misunderstood: (i) due to the limited sense in which this term is used in metabolic and genetic studies, (ii) because Toxoplasma and Besnoitia show no lag period, and (iii) because in the presence of pronounced immunity, where almost no multiplication occurs, "astronomical" generation times result from this exponential formula (26 (9, 41, 45 The specificity of macrophage-related immunity has always been a problem because nonspecifically activated macrophages may be appreciably more inhibitory than normal macrophages (37, 39) . However, specifically armed macrophages (2) usually show significantly greater inhibition than nonspecifically activated ones (22, 30, 46) . Similarly, kidney cells exposed to Toxoplasma or Besnoitia were better protected with homospecific than heterospecific combinations of immune lymphocytes, lymphocytes and macrophages, or supernatant ( Table  2 , Fig. 4 ). For example, multiplication ratios for Toxoplasma in specifically immune combinations were -2, but when exposed to activated macrophages they were 5.6, similar to when exposed to heterospecific lymphocytes or supernatants, with ratios of 6 to 8, the same range as with normal control lymphocytes.
Soluble mediators of immunity have been found in the supernatants of immune lymphocytes incubated with Toxoplasma antigen (4, 9, 25, 41, 44, 45) , with Listeria (5, 24, 38) , and with tuberculosis (27) . The mediators were used either with macrophages or with monocytes. We have identified separate and distinct mediators against Toxoplasma and Besnoitia. These mediators were effective not only in macrophages, but also in kidney cells and fibroblasts in the absence of macrophages (Table 2) . Such mediators could be diluted to 1:4 (Table 3) ; they appeared stable at -20oC, but were unstable at body temperature (Table 4 ). The loss of mediator activity after 20 to 40 h at 370C was as previously mentioned (4, 25) . Further characterization of the Toxoplasma mediator showed it to be sensitive to chymotrypsin and trypsin, but not to RNase and DNase; the Besnoitia mediator showed a lesser sensitivity to chymotrypsin and trypsin. The molecular weight of both mediators was 4,000 to 5,000. The mediators were specifically induced and specifically expressed, and they appeared to be active only in cells of the host species from which they were derived (Table 7) . These results suggest a similarity to transfer factor (28) and exclude the mediator from being identified as interferon, which is nonspecifically induced and expressed, or as one of the various lymphokines that are nonspecifically expressed and lack host specificity. Antibody effect was excluded by negative serological tests, by the mediator's effectiveness with homologous but not heterologous cells, and by the low molecular weight of the mediator identified. The mediator inhibits the growth of Toxoplasma through unidentified mechanisms. A perhaps similar "Toxoplasma growth-inhibitory factor" from antigen-exposed lymphocytes of immune mice was studied in mouse macrophages (43) . Its secretion was stimulated also by concanavalin A and phytohemagglutinin P and was inhibited by antithymocyte serum with complement and by cycloheximide and puromycin.
Certain seemingly divergent findings concerning the expression of immunity in "normal" macrophages and somatic cells should be discussed. Jones et al. (25) Whereas phagocytosis of Toxoplasma by macrophages is emphasized by several authors, consistent with the usual finding of a single parasitophorous vacuole, the active penetration by Toxoplasma of fibroblasts and of kidney cells is supported by the common finding of several parasitophorous vacuoles. A greater number of live than killed Toxoplasma has also been found in macrophages (46) , and the appearance of Toxoplasma in macrophages rendered nonphagocytic by treatment with cytochalasin suggests active penetration by organisms. The latter has also been observed, filmed, and studied by electron microscopy (1, 8) Since fibroblasts appear to be most responsive to immunity conferred by lymphocytes or mediator, a number of variations can be discussed using them as an example ( Table 9 ). Exposure of fibroblasts to lymphocytes and antigen for 3 h was not sufficient to confer immunity. However, after 24 h of incubation, enough mediator had been released by lymphocytes and sorbed by fibroblasts that they restricted the growth of Toxoplasma even after having been washed. The mediator, when applied to the fibroblasts at the time of infection, was usually protective, and if so, conferred immunity over a 24-h period if permitted to remain; however, if it was washed off after 3 h, it was not protective (not shown). Shirahata et al. (45) protected cells with mediator applied 2 h after infection.
Antibody was sometimes protective when it was applied before infection, but not regularly so. Although antibody with complement present in fresh hamster plasma may be destructive to extracellular Toxoplasma, antibody does not prevent cell-to-cell spread, as seen in hypercorticoid hamsters (16) where lymphocyte function (30) and possibly mediator production are defective.
The potential clinical relevancy of the mediator was indicated by experiments in young hamsters. Even a single i.p. injection of 2 ml of supernatant significantly delayed the death of these hamsters injected with 10 to 100 Besnoitia when compared with normal serum (Fig. 9) . Protection by mediator was significantly better than with high-titer antiserum with the lowest inoculum. Although only survival of animals will be convincing, probably requiring repeated injections of mediator, the present results suggest the mediator's effectiveness in vivo. Its low molecular weight compared with antibody, its intracellular effectiveness, and its functional link with specifically immune lymphocytes are consistent with previously observed modalities (9, 11, 12, 22, 25, 30) 
